A New Editor—Building on a
Tradition of Excellence
It is with great pleasure that I assume the position of Editor-in-Chief of Advances in Pulmonary Hypertension. The journal is
now in its 6th year of helping physicians by informing them of
important trends in caring for patients with pulmonary hypertension.
For the past 2 years, Vallerie V. McLaughlin, MD, as
Editor-in-Chief in 2005 and 2006, has shown me how to
orchestrate the journal into a state-of-the art reference for
pulmonary hypertension that has become a stunning success,
with a circulation that has grown to more than 36,000. From her timely topic
selections to her meticulous, watchful eye, Dr McLaughlin has set the stage for
the journal’s continued success and has provided us with healthy momentum
to this end. An enormous credit goes to the journal’s founding editor, Victor F.
Tapson, MD. Dr Tapson’s efforts in launching a journal with critical reviews of
the newest areas of diagnosis and treatments for patients with pulmonary
hypertension heralded a successful 3-year tenure, a tradition that continues
today.
In this, the 21st issue of the journal, Roxana Sulica, MD, has taken the role
of lead editor, overseeing three detailed reviews of the associations between hemoglobinopathies and pulmonary hypertension. The complex pathophysiology
is evident in the review by Drs Gladwin and Kato. The clinical aspects of sicklecell-
associated pulmonary hypertension are critically examined by Drs Machado
and Castro, and a look into the clinical facets of thallasemia-associated
pulmonary hypertension is provided by Drs Morris, Vichinsky, and Singer. These
reviews remind us of the broad scope of conditions that contribute to a seemingly
increasing prevalence of pulmonary vascular diseases that is being recognized
throughout the world. Finally, an expert roundtable discusses the similarities
and differences between pulmonary hypertension associated with hemoglobinopathies
and pulmonary arterial hypertension in its classic definition,
clearly calling attention to the need for therapeutic clinical trials.
I hope that you will enjoy this timely issue of Advances in Pulmonary
Hypertension, the only journal of its kind, and share in the rewards of future
issues.
Profiles in Pulmonary Hypertension:Gérald Simonneau, MD:
Pioneer, Mentor, and a Driving Force
in Pulmonary Hypertension Research
for His Colleagues (PDF)
When a physician’s curriculum vitae
totals 232 articles that he has either
authored or coauthored, there is little
doubt that he ranks high in the pantheon
of pulmonary hypertension
researchers. This is just the beginning
of Dr Gérald Simonneau’s credentials
as a world-class physician and
investigator, one of the most widely
published authors in the fields of
pulmonary hypertension, pulmonary vascular diseases,
and pneumology.
Hemolysis-Associated Endothelial Dysfunction and
Pulmonary Hypertension, an Emerging Cause of
Death in the Hemoglobinopathies (PDF)
Medical advances in the management of patients with sickle
cell disease (SCD), thalassemia, and other hemolytic anemias
have led to significant increases in life expectancy.
Improved public health with neonatal genetic screening,
parental and patient education, advances in red cell transfusion
medicine safety, aggressive iron chelation therapy,
penicillin prophylaxis for children under 6 years of age,
immunization, and hydroxyurea therapy have all likely contributed
to this effect on longevity. Now, as a generation
of patients with SCD and thalassemia ages, new chronic vascular
complications of these hemoglobinopathies develop.
PH Clinicians & Researchers and PH Resource Network
(PDF)
Notes
Editorial Advisory
Board
Editor-in-Chief Ronald J. Oudiz, MD
Associate Professor of Medicine
UCLA School of Medicine
Director, Liu Center for Pulmonary Hypertension
Division of Cardiology
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, California
Immediate Past Editor Vallerie V. McLaughlin, MD
Associate Professor of Medicine
Director, Pulmonary Hypertension Program
University of Michigan Health System
Ann Arbor, Michigan
Editor-in-Chief Elect Richard Channick, MD
Professor of Clinical Medicine
Pulmonary and Critical Care Division
University of California, San Diego Medical Center
San Diego, California
Associate Editors Erika Berman Rosenzweig, MD
Assistant Professor of Pediatrics
Department of Pediatrics
Columbia College of Physicians and Surgeons
New York, New York
Robert Frantz, MD
Consultant in Cardiovascular
Diseases and Internal Medicine
Assistant Professor of Medicine
Mayo Clinic College of Medicine
Rochester, Minnesota
Srinivas Murali, MD, FACC
Professor of Medicine
Drexel University College of Medicine
Director, Division of Cardiovascular Medicine
Medical Director, Gerald McGinnis Cardiovascular Institute
Allegheny General Hospital
Pittsburgh, Pennsylvania
Publisher
Pulmonary Hypertension Association
Jack Stibbs, Board Chair
Rino Aldrighetti, President
Donica Merhazion, Medical Services Associate Director
Publishing Staff
Stu Chapman, Executive Editor
Susan Chapman, Managing Editor
Heidi Green, Associate Editor
Gloria Catalano, Production Director
Michael McClain, Design Director
Editorial Offices
Advances in Pulmonary Hypertension
DataMedica
424 Dune Road Westhampton Beach, NY 11978
Tel: 631-288-7733
Fax: 631- 288-7744
Advances in Pulmonary Hypertension is circulated to
cardiologists, pulmonologists, rheumatologists and other selected
physicians by the Pulmonary Hypertension
Association
. The contents of the
articles are
independently determined ly the Editor
and the Editorial Advisory
Board.
Editorial Mission Advances in Pulmonary Hypertension is committed
to help physicians in their clinical decision
making by informing them of important
trends affecting their practice. Analyzing the
impact of new findings and covering current
information in the peer-reviewed literature,
Advances in Pulmonary Hypertension is published
four times a year. Advances in Pulmonary
Hypertension is the official journal
of the Pulmonary Hypertension Association.
Each article in this journal has been reviewed
and approved by members of the Editorial
Advisory Board.
Editorial Board
Todd Bull, MD
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado Health Sciences Center
Denver, Colorado
Murali Chakinala, MD
Director, Pulmonary Hypertension Clinic
Washington University School of Medicine
St. Louis, Missouri
Kristin Highland, MD
Assistant Professor
Division of Pulmonary and Critical Care
Director, Pulmonary Hypertension Clinic
Medical University of South Carolina
Charleston, South Carolina
Jim Maloney, MD
Associate Professor of Pulmonary and Critical Care Medicine
University of Colorado Health Sciences Center
Denver, Colorado
Ioana Preston, MD
Assistant Professor of Medicine
Tufts - New England Medical Center
Boston, Massachusetts
Zeenat Safdar, MD
Assistant Professor of Medicine
Department of Medicine, Pulmonary & Critical Care Section
Pulmonary Hypertension Center
Baylor College of Medicine
Houston, Texas
Rajan Saggar, MD
Assistant Professor
Division of Pulmonary and Critical Care
Medicine and Hospitalists
David Geffen School of Medicine
UCLA
Los Angeles, California
Robert Schilz, DO, PhD
Medical Director of Lung
Transplantation and Pulmonary Vascular Disease
University Hospital of Cleveland
Case Western Reserve University
Cleveland, Ohio
Francisco Soto, MD, MS
Assistant Professor
Director, Pulmonary Hypertension Program
Medical College of Wisconsin
Milwaukee, Wisconsin
Roxana Sulica, MD
Assistant Professor of Medicine
Albert Einstein College of Medicine
Director, Beth Israel Pulmonary Hypertension Program
Beth Israel Medical Center
New York, New York
The
information provided on the PHA website is provided for general information
only. It is not intended as legal, medical or other professional
advice, and should not be relied upon as a substitute for consultations
with qualified professionals who are familiar with your individual
needs.
It is with great pleasure that I assume the position of Editor-in-Chief of Advances in Pulmonary Hypertension. The journal is
now in its 6th year of helping physicians by informing them of
important trends in caring for patients with pulmonary hypertension.
For the past 2 years, Vallerie V. McLaughlin, MD, as
Editor-in-Chief in 2005 and 2006, has shown me how to
orchestrate the journal into a state-of-the art reference for
pulmonary hypertension that has become a stunning success,
with a circulation that has grown to more than 36,000. From her timely topic
selections to her meticulous, watchful eye, Dr McLaughlin has set the stage for
the journal’s continued success and has provided us with healthy momentum
to this end. An enormous credit goes to the journal’s founding editor, Victor F.
Tapson, MD. Dr Tapson’s efforts in launching a journal with critical reviews of
the newest areas of diagnosis and treatments for patients with pulmonary
hypertension heralded a successful 3-year tenure, a tradition that continues
today.
